It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Adipose tissue resident macrophages have important roles in the maintenance of tissue homeostasis and regulate insulin sensitivity for example by secreting pro-inflammatory or anti-inflammatory cytokines. Here, we show that M2-like macrophages in adipose tissue regulate systemic glucose homeostasis by inhibiting adipocyte progenitor proliferation via the CD206/TGFβ signaling pathway. We show that adipose tissue CD206+ cells are primarily M2-like macrophages, and ablation of CD206+ M2-like macrophages improves systemic insulin sensitivity, which was associated with an increased number of smaller adipocytes. Mice genetically engineered to have reduced numbers of CD206+ M2-like macrophages show a down-regulation of TGFβ signaling in adipose tissue, together with up-regulated proliferation and differentiation of adipocyte progenitors. Our findings indicate that CD206+ M2-like macrophages in adipose tissues create a microenvironment that inhibits growth and differentiation of adipocyte progenitors and, thereby, control adiposity and systemic insulin sensitivity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 First Department of Internal Medicine, University of Toyama, Toyama-shi, Toyama, Japan
2 First Department of Internal Medicine, University of Toyama, Toyama-shi, Toyama, Japan; Department of Nutrition, Faculty of Medicine, University of Hasanuddin, Kota Makassar, Sulawesi Selatan, Indonesia
3 Department of Pathology, University of Toyama, Toyama-shi, Toyama, Japan
4 Department of Diagnostic Pathology, University of Toyama, Toyama-shi, Toyama, Japan; Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
5 Division of Kampo Diagnostics, Institute of Natural Medicine, University of Toyama, Toyama-shi, Toyama, Japan
6 Department of Immune Regulation, Research Center for Hepatitis and Immunology, Research Institute, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan
7 Department of Immunobiology and Pharmacological Genetics, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama-shi, Toyama, Japan; JST, PRESTO, Kawaguchi, Saitama, Japan
8 Department of Immunobiology and Pharmacological Genetics, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama-shi, Toyama, Japan; Toyama Prefectural Institute for Pharmaceutical Research, Imiz-shi, Toyama, Japan
9 Department of Diagnostic Pathology, University of Toyama, Toyama-shi, Toyama, Japan
10 Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo, Japan
11 Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo, Japan; Department of Molecular Diabetic Medicine, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan
12 Department of Laboratory Animal Medicine, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan; Section of Animal Models, Department of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan
13 Doctoral Program in Sports Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan
14 Department of Molecular Metabolic Regulation, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan
15 Department of Molecular Neuroscience, University of Toyama, Toyama-shi, Toyama, Japan
16 Department of Metabolism and Nutrition, University of Toyama, Toyama-shi, Toyama, Japan
17 Department of Disease Control, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan